Use of IL-6 in the preparation of pharmaceutical compositions to treat and prevent liver lesions

摘要

Use of IL-6 or a mutein, isoform, fused protein, functional derivative, active fraction or salt thereof, in the manufacture of a medicine for the treatment of liver cirrhosis treated by liver resection, said medicine optionally comprising a pharmaceutically acceptable vehicle , wherein the medicament is for administration at a dose ranging from 0.1 to 10 mcg / kg; and wherein additionally the functional derivative comprises at least one polyethylene moiety attached to one or more functional groups that occur in the form of one or more side chains at the amino acid residues and the mutein, isoform, fused protein, functional derivative, fraction active or salt is capable of binding to the gp80 IL-6 binding site.